Search results
GSK, Boehringer Put Profits Over User Safety, Zantac Jury Told
Insurance Journal· 16 hours agoDrugmakers GSK Plc and Boehringer Ingelheim GmbH prioritized profits over consumer safety by hiding...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 6 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 8 hours agoThe majority of the large drugmakers have already reported their results. Many of these companies...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
San Antonio Express-News· 6 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply
The Business of Fashion· 4 days agoShortages have left patients already on the medications searching for their next dose and stymied...
Amgen scraps experimental weight loss pill, moves forward with injection
NBC Philadelphia· 4 days agoAmgen is scrapping an experimental weight loss pill but moving forward with an injection. Amgen is...
The global synthetic drugs crisis has hit West Africa, where people are digging up human bones to...
INSIDER via Yahoo News· 1 day agoDrugmakers change the specific ingredients so fast — and produce the drugs in such massive...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 3 days agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 6 days agoThe crackdown is the latest assault against what the agency regards as drugmakers’ patent ploys...
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
Reuters via Yahoo Finance· 6 hours agoWHY IT'S IMPORTANT Indian generic drugmakers Dr. Reddy's Laboratories, Cipla and Sun Pharmaceutical Industries have benefited from strong sales and price recovery in the key ...